| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27,264 |
25,632 |
$1.38M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
11,803 |
11,724 |
$929K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
9,660 |
9,585 |
$797K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,332 |
20,425 |
$779K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
8,452 |
8,288 |
$645K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
59,972 |
27,522 |
$627K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,960 |
5,881 |
$518K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
11,036 |
7,640 |
$88K |
| 92553 |
|
2,773 |
2,765 |
$83K |
| 90461 |
|
15,071 |
12,612 |
$80K |
| 99381 |
|
970 |
948 |
$78K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
574 |
570 |
$46K |
| 99429 |
|
1,167 |
1,157 |
$38K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,125 |
1,107 |
$32K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
416 |
411 |
$20K |
| 96160 |
|
4,098 |
4,042 |
$9K |
| 99000 |
|
486 |
472 |
$5K |
| 97169 |
|
186 |
183 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
92 |
92 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
33 |
33 |
$2K |
| 99173 |
|
5,892 |
5,854 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
84 |
82 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
13 |
13 |
$766.61 |
| 0011A |
|
13 |
13 |
$480.00 |
| 0012A |
|
12 |
12 |
$480.00 |
| CP002 |
|
45 |
41 |
$441.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
26 |
16 |
$361.40 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
14 |
$149.63 |
| 90686 |
|
10,935 |
10,781 |
$110.31 |
| 90661 |
|
1,472 |
1,470 |
$1.28 |
| 83655 |
|
120 |
120 |
$0.62 |
| 90648 |
|
5,804 |
5,745 |
$0.03 |
| 90723 |
|
4,546 |
4,498 |
$0.02 |
| 90680 |
|
4,444 |
4,405 |
$0.02 |
| 90670 |
|
5,614 |
5,571 |
$0.01 |
| 90671 |
|
865 |
857 |
$0.01 |
| 90700 |
|
664 |
658 |
$0.00 |
| 90715 |
|
322 |
318 |
$0.00 |
| 90633 |
|
3,530 |
3,502 |
$0.00 |
| 90734 |
|
1,380 |
1,372 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
380 |
374 |
$0.00 |
| 90710 |
|
1,125 |
1,115 |
$0.00 |
| 90707 |
|
1,182 |
1,172 |
$0.00 |
| 90380 |
|
15 |
14 |
$0.00 |
| 90716 |
|
1,155 |
1,146 |
$0.00 |
| 90696 |
|
1,081 |
1,071 |
$0.00 |
| 90651 |
|
1,620 |
1,613 |
$0.00 |
| 90620 |
|
604 |
600 |
$0.00 |
| 90698 |
|
864 |
864 |
$0.00 |
| 90744 |
|
245 |
245 |
$0.00 |
| 90677 |
|
545 |
540 |
$0.00 |